Loading stock data…
Haleon plc (HLN)
$9.33+0.09 (+0.97%)
After Hours$9.33+0.00 (+0.00%)· Last close Jun 29
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Haleon plc in the Healthcare sector is trading at $9.33 with a market capitalization of $39.9B. Wall Street consensus targets $11.69 (5 analysts), implying a +25.3% move over the next 12 months. The stock is currently 17% below its 52-week high of $11.28, remaining 2.8% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +25.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q4 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Total Revenue | — | — | $2.76B↓ | $2.78B↑ | $2.77B |
| Gross Profit | — | — | $1.53B↓ | $1.75B↑ | $1.71B |
| Operating Income | — | — | $350.00M↓ | $705.00M↑ | $496.00M |
| Net Income | — | — | $231.00M↓ | $485.00M↑ | $303.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$39.91B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.04%
ROE
Average efficiency. Growth may require heavy reinvestment.
8.78%
Volume
Today's trading volume
8.72M
Recent News
Unilever exploring $4 billion bid for Thorne supplements
L Catterton, the LVMH-backed private equity firm that took Thorne private for $680 million in 2023, is seeking a valuation of up to $4 billion
Is Haleon plc (HLN) Stock Still a Growth Opportunity After Analyst Downgrade?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Haleon plc (NYSE:HLN) is among the best healthcare stocks. TheFly reported on June 16 that Rothschild & Co Redburn analyst Edward Lewis lowered his rating on HLN from Buy to Neutral and assigned a price target of 365 […]
Haleon (HLN) Issues Voluntary Nationwide Recall for Specific Gas-X Extra Strength Softgels
Haleon (NYSE:HLN) is one of the top value stocks to buy under $10. On June 4, Haleon issued a voluntary nationwide recall for four specific lots of Gas-X Extra Strength Softgels (125mg) in 120-count and 72-count packaging. The recall was initiated due to potential contamination from a diluted propylene glycol-based coolant that leaked from a […]
LCUT or HLN: Which Is the Better Value Stock Right Now?
LCUT vs. HLN: Which Stock Is the Better Value Option?
US Equity Futures Higher Pre-Bell as Trump Tries to Keep Fragile Middle East Ceasefire Intact Amid New Israel-Iran Clashes
US equity futures were edging higher pre-bell Monday as President Donald Trump tried to hold togethe